Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY

May.08
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japanese Tobacco (JT) reports Q1 2026 revenue of 924 billion yen, a 15.2% increase; operating profit rises 24.7%.

Core Data Overview:

  • Overall Performance: Q1 2026 reported revenue was JPY 924.0 billion (approx. USD 5.914 billion), up 15.2% year-over-year (YoY); operating profit was JPY 304.6 billion (approx. USD 1.949 billion), up 24.7% YoY.
  • Next-Generation Products (RRP/Reduced-Risk Products): RRP shipment volume reached 4.3 billion units, an increase of 44.2% YoY; related revenue was JPY 43.5 billion (approx. USD 278 million), up 63.8% YoY.
  • Combustibles: Global shipment volume was 131.3 billion units, down 0.1% YoY.
  • Full-Year Guidance: FY2026 total consolidated revenue is projected at JPY 3.697 trillion (approx. USD 23.66 billion), with an operating profit forecast of JPY 921.0 billion (approx. USD 5.894 billion).

According to the Q1 2026 financial report released by Japan Tobacco Inc. (JT) on May 8, 2026, the company recorded YoY growth in both single-quarter revenue and operating profit. The financial changes were primarily driven by foreign exchange factors (a weaker Japanese Yen), pricing adjustments in combustibles, and increased sales volume in Reduced-Risk Products (RRP).

 

I. Financial Data Overview

 

Revenue: 1Q26 total revenue was JPY 924.0 billion (approx. USD 5.914 billion), an increase of 15.2% YoY. Core revenue at constant FX was JPY 842.5 billion, up 9.8% YoY.

 

Operating Profit: 1Q26 operating profit was JPY 304.6 billion (approx. USD 1.949 billion), up 24.7% YoY. Adjusted operating profit (AOP) was JPY 315.5 billion, up 22.8% YoY (or up 20.5% at constant FX).

 

Net Profit: Q1 profit was JPY 197.0 billion (approx. USD 1.261 billion), up 27.3% YoY.

 

II. Business Segment Operational Data

 

1. Next-Generation Products (RRP/Reduced-Risk Products) Segment

In Q1, JT's NGP segment (primarily comprising heated tobacco products) showed an upward trend in both volume and revenue metrics:

 

Revenue Performance: 1Q26 RRP-related revenue was JPY 43.5 billion (approx. USD 278 million), up 63.8% compared to JPY 26.6 billion in the same period last year.

 

Shipment Volume Data: Total RRP shipment volume was 4.3 billion units, up 44.2% YoY. Within this, Heated Products shipment volume accounted for 3.7 billion units, up 57.0% YoY.

 

Market Expansion: The financial report indicated that the heated tobacco device Ploom AURA, launched last year, is undergoing continued geographical expansion. As of May 2026, the product is available in 25 markets.

 

Core Market (Japan): In the domestic Japanese market, RRP volume was 3.4 billion units, up 42.2% YoY, driven by Ploom volume of 3.1 billion units, which increased by 51.1% YoY. Influenced by temporary incremental demand ahead of an excise tax-led price revision on heated tobacco products in Q1, JT's Heated Products Share of Segment (SoS) in Japan rose to 15.8%, an increase of 3.1 percentage points YoY.

 

2. Combustibles Segment

 

Shipment Volume: Q1 total combustibles volume was 131.3 billion units, down slightly by 0.1% YoY. Global Flagship Brands (GFB, including Winston, Camel, MEVIUS, and LD) volume was 96.7 billion units, up 1.0% YoY.

 

Regional Performance:

  • Asia: Combustibles volume was 28.5 billion units, up 3.8% YoY.
  • Western Europe: Combustibles volume was 22.5 billion units, down 3.5% YoY.
  • EMA (Eastern Europe, MENEAT, Americas, and Global Travel Retail): Combustibles volume was 80.2 billion units, down 0.4% YoY.
  • Market Share: JT recorded total tobacco market share growth in over 45 markets globally, including Italy, the Philippines, Spain, Turkey, and the USA.

3. Processed Food Business

 

Q1 revenue was JPY 37.8 billion, an increase of 3.7% YoY; adjusted operating profit was JPY 1.7 billion, compared to JPY 0.8 billion in the same period last year. The profit increase was primarily driven by price revisions for frozen udon noodles in the frozen and ambient foods business, which more than offset higher raw material costs.

 

III. FY2026 Full-Year Guidance

 

In this financial report, JT maintained the annual forecast data issued as of February 2026:

 

Revenue Projection: FY2026 consolidated revenue is projected at JPY 3.697 trillion (approx. USD 23.661 billion), up 6.6% YoY.

Profit Projection: Full-year operating profit is forecast at JPY 921.0 billion (approx. USD 5.894 billion), up 6.2% YoY; full-year net profit is forecast at JPY 570.0 billion (approx. USD 3.648 billion), up 14.2% YoY.

 

Base Assumptions: JT anticipates that the total global tobacco industry volume and GFB volume in 2026 will decrease by approximately 1.0% or remain flat compared to 2025.

 

(Note: USD figures in the text are estimated based on the actual Q1 exchange rate of 100 JPY = 0.64 USD disclosed in the financial report and are for reference only.)

 

Image source: Japan Tobacco

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
Product | ZYN Adds Tropical Flavor and Expands 1.5mg Nicotine Options in the Philippines
ZYN has expanded its nicotine pouch portfolio in the Philippines with the addition of Cool Breeze 1.5mg and Tropical in 3mg and 6mg strengths. Public information shows that 1.5mg is among the lower nicotine strengths offered by ZYN in the Philippine market and is positioned for adult nicotine consumers who are new to nicotine pouches.
PMI
Jun.08
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia will strengthen surveillance of vapes amid growing concerns over drug-laced e-cigarettes. The National Food and Drug Monitoring Agency, or BPOM, will soon take charge of monitoring nationwide vape distribution and said it will work with the National Narcotics Agency, or BNN. BNN recently floated a plan to completely ban e-cigarettes, saying a total ban was the only way to prevent liquid narcotics.
May.11 by 2FIRSTS.ai
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai